Molnupiravir, also known by its brand name Nupiravir, represents a significant advancement in the effort against COVID-19. This oral antiviral medicine works by introducing errors into the SARS-CoV-2's genetic sequence, effectively preventing its copying and spread within the individual. While early data showed a considerable reduction in admission